Gene · 3384
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editing a gateway for cell therapy across the blood-brain barrier. | Brain | 2023 | 36397727 | PubTator, text mining | PubMed |
| Endothelial transmigration hotspots limit vascular leakage through heterogeneous expression of ICAM-1. | EMBO Rep | 2023 | 36382783 | PubTator, text mining | PubMed |
| Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy. | Cardiovasc Res | 2023 | 35394031 | PubTator, text mining | PubMed |
| Systematic characterization of extracellular glycoproteins using mass spectrometry. | Mass Spectrom Rev | 2023 | 34047389 | PubTator, text mining | PubMed |
| Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. | Gene Ther | 2023 | 33456057 | PubTator, text mining | PubMed |
| ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity. | Front Immunol | 2022 | 36895258 | PubTator, text mining | PubMed |
| Identification and classification of distinct surface markers of T regulatory cells. | Front Immunol | 2022 | 36741366 | PubTator, text mining | PubMed |
| Walk on the wild side: SIV infection in African non-human primate hosts-from the field to the laboratory. | Front Immunol | 2022 | 36713371 | PubTator, text mining | PubMed |
| Secretomes derived from osteogenically differentiated jaw periosteal cells inhibit phenotypic and functional maturation of CD14+ monocyte-derived dendritic cells. | Front Immunol | 2022 | 36700194 | PubTator, text mining | PubMed |
| Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression. | Front Immunol | 2022 | 36685556 | PubTator, text mining | PubMed |
| CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders. | Int J Mol Sci | 2022 | 36613684 | PubTator, text mining | PubMed |
| Tissue-Protective and Anti-Inflammatory Landmark of PRP-Treated Mesenchymal Stromal Cells Secretome for Osteoarthritis. | Int J Mol Sci | 2022 | 36555578 | PubTator, text mining | PubMed |
| Identification of JPX-RABEP1 Pair as an Immune-Related Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension by Bioinformatics and Experimental Analyses. | Int J Mol Sci | 2022 | 36555200 | PubTator, text mining | PubMed |
| Apple Derived Exosomes Improve Collagen Type I Production and Decrease MMPs during Aging of the Skin through Downregulation of the NF-κB Pathway as Mode of Action. | Cells | 2022 | 36552714 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. | Biomolecules | 2022 | 36551272 | PubTator, text mining | PubMed |
| Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells. | Commun Biol | 2022 | 36543997 | PubTator, text mining | PubMed |
| Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis. | Cell Rep Med | 2022 | 36543113 | PubTator, text mining | PubMed |
| Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes. | Clin Transl Med | 2022 | 36536495 | PubTator, text mining | PubMed |
| Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. | Cell Death Dis | 2022 | 36535926 | PubTator, text mining | PubMed |
| Role of Ezrin in Asthma-Related Airway Inflammation and Remodeling. | Mediators Inflamm | 2022 | 36530558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3384/papers?page=13